glp-1 agonist fda approval just approved orforglipron (Foundayo), Eli Lilly's oral receptor for obesity. In the ATTAIN-1 phase 3 trial (n=3,127), published in the New England Journal of Medicine, patients on the highest GLP-1 Medications for Weight Loss:

For the capsule shells we use custom-made HPMC capsules that, unlike most other HPMC and pullulan capsules on the market, are 100% free from controversial additives such as carrageenans and PEG

PURE Beauty & Brighten IV Features biotin, B-complex vitamins, and Vitamin C Nourishes hair, skin, and nails Enhances anti-aging and brightening effects Perfect for: Brides, photo shoots, or anyone seeking a polished glow

PMID 3052273

not for safety or efficacy guidance

Indirect Assessment of Mucosal Integrity by Potential Blood Biomarkers Both ex vivo and the direct in vivo tests for intestinal permeability are time and labor-intensive and are not readily available in most labs